{
    "2018-04-19": [
        [
            {
                "time": "2018-04-16",
                "original_text": "P&G, GE and IBM Need to Innovate; Has Starbucks' Stock Grown Ice Cold?--ICYMI",
                "features": {
                    "keywords": [
                        "innovate",
                        "Starbucks",
                        "stock"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "consumer goods",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-17",
                "original_text": "Healthcare ETFs in Focus After Johnson & Johnson Q1 Earnings",
                "features": {
                    "keywords": [
                        "healthcare",
                        "ETFs",
                        "Johnson & Johnson",
                        "Q1 earnings"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-18",
                "original_text": "3 Drugs That Are Moving the Needle at Johnson & Johnson",
                "features": {
                    "keywords": [
                        "drugs",
                        "Johnson & Johnson",
                        "moving the needle"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}